The Triton Clinical Trial Programme: Evaluation of the Parp Inhibitor Rucaparib in Patients With Metastatic Castration-Resistant Prostate Cancer (mCRPC) Associated With Homologous Recombination Deficiency (HRD)
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY（2017）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要